Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice

BACKGROUND: Histone deacetylase (HDAC) inhibitors, developed as promising anti-tumor drugs, exhibit their anti-inflammatory properties due to their effects on reduction of inflammatory cytokines. OBJECTIVE: To investigate the protective effect of butyrate, a HDAC inhibitor, on lipopolysaccharide (LP...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ni, Yun-Feng, Wang, Jian, Yan, Xiao-Long, Tian, Feng, Zhao, Jin-Bo, Wang, Yun-Jie, Jiang, Tao
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2848144/
https://ncbi.nlm.nih.gov/pubmed/20302656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-11-33
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items